Format

Send to

Choose Destination
Regen Med. 2011 Nov;6(6 Suppl):85-7. doi: 10.2217/rme.11.76.

Brüstle v. Greenpeace: implications for stem cell research.

Author information

1
Lawford Davies Denoon, 14A Clerkenwell Green, London, EC1R 0DP, UK. alex@lawforddaviesdenoon.com

Abstract

On 10 March 2011, the Advocate General of the Court of Justice for the European Union issued an Opinion, which essentially recommended that certain inventions related to human embryonic stem cells should not be patentable. Since the publication of the Opinion, the case (Brüstle v. Greenpeace Case C-34/10) has generated a lot of commentary, including numerous articles and discussion in the UK parliment. This article will seek to summarize the case and discuss its practical ramifications.

PMID:
21999267
DOI:
10.2217/rme.11.76
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center